相关实验视频

Updated: May 6, 2026

Thermal Ablation for the Treatment of Abdominal Tumors

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

甲状腺恶性瘤的新趋势:T1乳头甲状腺癌的最小侵入性热切除皮技术

Pierre Yves Marcy¹,

¹IMASUD Diagnostic and Interventional Radiology Group, PolyClinique les Fleurs, Quartier Quiez, ELSAN MEDIPOLE SUD, 83189 Ollioules, France.

Current oncology (Toronto, Ont.)

|August 27, 2025

概括

高频超声波和超声波引导的程序在20世纪90年代末显著改善了甲状腺结节的治疗. 这些创新提高了甲状腺结节的诊断准确性和治疗选择.

科学领域:

内分泌学
放射学
外科瘤学

背景情况:

甲状腺结节很常见, 需要准确的诊断和管理策略.
在20世纪90年代末之前,传统的甲状腺结节评估方法存在局限性.

研究的目的:

突出技术进步对甲状腺结节管理的影响.
审查高频超声波和皮肤透手术的好处.

主要方法:

对甲状腺结节的诊断和干预技术的审查.
专注于高频超声波的引入和应用.
通过超声指导的皮肤手术的分析.

主要成果:

高频超声波 (HFUS) 提高了甲状腺结节的可视化和特征.
超声波指导的皮肤透程序提供了最少的侵入性诊断和治疗选择.
这些进步带来了更好的患者结果和更精确的治疗方法.

结论:

上世纪90年代末在甲状腺结节治疗方面出现了重大转折点.
HFUS和美国指导的程序成为内分泌学和放射学中不可或缺的工具.
这些技术仍然是现代甲状腺结节管理的基础.

更多相关视频

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Published on: September 15, 2023

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...